We found an increase in incidence of HER2+ tumours with Ki-67 ≥ 15% and Ki-67 ≥ 30%, while according to mitotic count, there was an increase in tumours with low mitotic count (≤3.6 mitoses/mm2). The gene discussed is ERBB2; the disease is neoplasm.